| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 17,927,892 | 19,703,160 | 17,110,425 | 14,745,702 |
| Cost of goods sold | 16,546,721 | 17,623,816 | 14,507,807 | 13,581,888 |
| Gross profit | 1,381,171 | 2,079,344 | 2,602,618 | 1,163,814 |
| General and administrative expenses | 1,800,162 | 10,609,632 | 2,040,341 | 1,490,485 |
| Salaries and wages | 1,397,657 | 1,949,866 | 1,919,950 | 1,868,443 |
| Sales and marketing expenses | 19,352 | 35,585 | 64,794 | 21,706 |
| Research and development costs | 0 | 410,760 | 18,337 | 74,637 |
| Impairment charges | NaN | 162,785 | NaN | NaN |
| Depreciation and amortization expense | 348,179 | 317,141 | 377,911 | 353,862 |
| Total operating expenses | 3,565,350 | 13,485,769 | 4,421,333 | 3,809,133 |
| Loss from operations | -2,184,179 | -11,406,425 | -1,818,715 | -2,645,319 |
| Other income (expense), net | 441,062 | -117,539 | -5,577 | -42,190 |
| Interest expense | 423,229 | 654,801 | 669,150 | 388,814 |
| Interest income | 46,673 | 98,602 | 100,698 | 105,787 |
| Gain on equity investments, net | -11,252 | 12,374* | 2,998 | NaN |
| Gain on extinguishment of debt | NaN | 17,152.5* | NaN | NaN |
| Non-cash interest expense | 390,350 | 175,938* | 201,447 | 163,103 |
| Gain on equity investments, net | NaN | NaN | NaN | 2,639 |
| Change in fair value of derivative liability | 231,968 | -1,056,586* | -311,778 | NaN |
| Foreign currency transaction, net | NaN | NaN | NaN | 442,524 |
| Gain on digital assets | NaN | NaN | 57 | NaN |
| Unrealized loss on digital assets | NaN | -147,229* | NaN | NaN |
| Gain/(loss) on digital assets | -442,439 | NaN | NaN | NaN |
| Change in fair value of convertible notes | 239,480 | 2,128,788.5* | -2,178,039 | -139,592 |
| Foreign currency transaction, net | -313,157 | 1,155,658* | -271,937 | NaN |
| Total other income (expense), net | -621,244 | 1,260,482 | -3,534,175 | -182,749 |
| Loss before income taxes | -2,805,423 | -10,145,943 | -5,352,890 | -2,828,068 |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net loss | NaN | NaN | -5,352,890 | -2,828,068 |
| Deemed dividend on issuance of warrants | NaN | 0* | 0 | NaN |
| Deemed dividend on warrant exchange/modification | NaN | 0* | 0 | NaN |
| Net loss | -2,805,423 | -10,145,943 | -5,352,890 | -2,828,068 |
| Net loss attributable to common stockholders | -2,805,423 | -10,145,943 | NaN | NaN |
| Foreign currency translation adjustment, net | -295,061 | -382,567 | 255,263 | 1,562,470 |
| Total comprehensive loss | -3,100,484 | -10,528,510 | -5,097,627 | -1,265,598 |
| Basic EPS | -0.06 | -0.295 | -0.17 | -0.1 |
| Diluted EPS | -0.06 | -0.295 | -0.17 | -0.1 |
| Basic Average Shares | 47,087,621 | 35,739,904 | 30,625,284 | 28,753,492 |
| Diluted Average Shares | 47,087,621 | 35,739,904 | 30,625,284 | 28,753,492 |
Cosmos Health Inc. (COSM)
Cosmos Health Inc. (COSM)